Imidazothiazoles
AssigneeRolic AG
InventorsRichard Buchecker, Willy Friedrichsen, Jurg Funfschilling, Sandra Lupfert
Life of this patent
Estimating the term…
Loading patent…
AssigneeRolic AG
InventorsRichard Buchecker, Willy Friedrichsen, Jurg Funfschilling, Sandra Lupfert
Estimating the term…
Compounds of the general formula ##STR1## have a pronounced tendency to form liquid crystalline S (smectic) phases. Thus, optically inactive compounds of the formula I also have a tilted smectic phase, in particular an S.sub.C phase, in addition to a nematic phase. In contrast, many optically active compounds of the formula I additionally have, inter alia, a tilted smectic chiral phase, in particular a chiral S.sub.C phase, in addition to a cholesteric phase. The stated compounds are therefore particularly suitable as components and as dopants, respectively, for the preparation of a very wide range of liquid crystalline mixtures. The class of compounds comprising compounds of the general formula I offers a broad range of novel components and mixtures for optimization and modification of liquid crystalline mixtures.
An imidazothiazole derivative of the formula ##STR7## in which the symbols m, n, R.sup.1 and R.sup.2 have the following meanings:
##STR9##
A liquid crystalline mixture having at least two components, comprising a content of at least one imidazothiazole derivative of the formula ##STR10## in which the symbols m, n, R.sup.1 and R.sup.2 have the following meanings:
An optical or electro optical apparatus containing at least one imidazothiazole derivative of the formula ##STR13## in which the symbols m, n, R.sup.1 and R.sup.2 have the following meanings:
An imidazothiazole derivative of the formula ##STR15## which is optically active and in which the symbols m, n, R.sup.1 and R.sup.2 have the following meanings:
Dependencies are inferred from the claim text.